Answers are grounded in this paper and cite their sources.
Review highlights T-cell involvement in salivary gland dysfunction in autoimmune Sjögren's disease, suggesting new treatment avenues.
Sjögren's disease (SjD) is a chronic, systemic autoimmune disease that mainly targets saliva- and tear-producing glands. T-cells are a substantial immune cell subset involved in SjD pathogenesis, including break of tolerance toward self, and constitute a major part of tissue-resident and infiltrating immune cells in salivary glands (SGs) of patients with SjD. CD4⁺ T-cells provide help to B-cells, thereby contributing to B-cell hyperactivity in this disease. Yet, interactions between T-cells and non-immune cells, including epithelial cells and fibroblasts, and how such interactions contribute to the dysfunction of the glands are incompletely understood. Although CD4⁺ T helper cells have long been a major focus of research due to their dominance within inflammatory foci and their role in B-cell differentiation, growing evidence also implicates CD8⁺ T-cells in pathogenic processes within SG tissue. In this review, novel findings regarding the role of T-cells in SjD pathogenesis are discussed, focusing on their phenotype and function in SGs. Furthermore, treatments targeting T-cells directly or indirectly that have demonstrated clinical efficacy in SjD are reviewed. Studying the impact of these treatments on T-cells may shed new light on their role in SjD pathogenesis.
No takes yet. Share an insight, caveat, or question.
Verstappen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: